Intraocular pressure control after trabeculectomy in the patients with primary open angle glaucoma and pseudoexfoliative glaucoma followed up for 3 to 5 years
Scindeks Assistant SCIndeks Assistant: Journal Management System

How to Cite

1.
Marić V, Marković V, Božić M, Marjanović I, Hentova Senćanić P, Kontić D. Intraocular pressure control after trabeculectomy in the patients with primary open angle glaucoma and pseudoexfoliative glaucoma followed up for 3 to 5 years. Vojnosanit Pregl [Internet]. 2021 Mar. 5 [cited 2026 Jul. 12];76(8). Available from: https://asistent.ceon.rs/index.php/vsp/article/view/12824

Abstract

Abstract

 

Background/Aim. Trabeculectomy is a safe procedure which effectively reduces the intraocular pressure (IOP). IOP is the most frequent indicator of success after glaucoma surgery. The aim of this work was to evaluate the long-term pressure control in primary open-angle glaucoma (POAG) and in pseudoexfoliative glaucoma (XFG) after primary trabeculectomy without the use of mitomycin-C (MMC), 3 to 5 years after trabeculectomy. Methods. This study involved a retrospective evaluation of 332 consecutive patients (352 eyes), 174 patients (188 eyes) with POAG (mean age of 64.0 ± 8.6 years) and 158 patients (164 eyes) with XFG (mean age of 70.7 ± 8.9 years) who underwent primary trabeculectomy between January 2007 and December 2009 at the Clinic for Eye Diseases, Clinical Center of Serbia in Belgrade. A successful control of IOP was defined as achieving IOP ≤ 21 mmHg without medication (complete success), or with a single topical medication (qualified success). Results. According to the type of glaucoma POAG/XFG preoperative IOP was 28.4 ± 6.3/30.4 ± 8.4 mmHg, respectively (p = 0.311) and last postoperative IOP was 16.9 ± 5.2/18.7 ± 5.9 mmHg, respectively (p = 0.681). According to the Kaplan-Meier survival curve, the complete success in the group with POAG in 1, 3 and 5 years were 85%, 75% and 58% and in the group with XFG were 82%, 70% and 56%, respectively. There was no statistically significant difference in the complete success rates between the patients with POAG and XFG. Conclusion. The primary goal of surgery was to achieve a sufficiently low IOP without additional medication, thus preventing progression of glaucomatous damage. In our study, the complete success in the group with POAG was achieved in 75% and 58% of the patientsin the period of 3 and 5 years after surgery, respectively and in the group with XFG complete success was achieved in 70% and 56% of the patients respectively.

Keywords

glaucoma open angle
exfoliation syndrome
trabeculectomy
intraocular pressure
treatment outcome
DOI: 10.2298/VSP161228178M

References

REFERENCES

Buys YM, Chipman ML, Zack B, Rootman DS, Slomovic AR, Trope GE. Prospective randomized comparison of one- versus two-site Phacotrabeculectomy two-year results. Ophthalmology 2008; 115(7): 1130–3.e1.

Shaarawy T, Flammer J, Haefliger IO. Reducing intraocular pres-sure: Is surgery better than drugs?. Eye (Lond) 2004; 18(12): 1215–24.

Chen G, Li W, Jiang F, Mao S, Tong Y. Ex-PRESS Implantation versus Trabeculectomy in Open-Angle Glaucoma: A Meta-Analysis of Randomized Controlled Clinical Trials. PLoS One 2014; 9(1): e86045.

Cairns JE. Trabeculectomy. Preliminary report of a new me-thod. Am J Ophthalmol 1968; 66(4): 673–9.

Rao K, Ahmed I, Blake DA, Ayyala RS. New devices in glau-coma surgery. Expert Revi Ophthalmol 2009; 4(5): 491–504.

He M, Wang W, Zhang X, Huang W. Ologen implant versus Mi¬tomycin C for trabeculectomy: A Systematic Review and Meta-Analysis. PLoS One 2014; 9(1): e85782.

Fernández S, Pardiñas N, Laliena JL, Pablo L, Díaz S, Pérez S, et al. Long-term tensional results after trabeculectomy. A com-parative study among types of glaucoma and previous medical treatment. Arch Soc Esp Oftalmol 2009; 84(7): 345–51. (Spanish)

Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: Risk factors and out-comes. Ophthalmology 2012; 119(4): 694–702.

Bevin TH, Molteno AC, Herbison P. Otago Glaucoma Surgery Out¬come Study: Long-term results of 841 trabeculectomies. Clin Experiment Ophthalmol 2008; 36(8): 731–7.

Jordan JF, Wecker T, Oterendorp C, Anton A, Reinhard T, Boehringer D,et al. Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol 2013; 251(12): 2753–60.

Parc CE, Johnson DH, Oliver JE, Hattenhauer MG, Hodge DO. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 2001; 132(1): 27–35.

Mills KB. Trabeculectomy: A retrospective long-term follow-up of 444 cases. Br J Ophthalmol 1981; 65(11): 790–5.

Watson PG, Grierson I. The place of trabeculectomy in the treatment of glaucoma. Ophthalmology 1981; 88(3): 175–96.

Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Oph-thalmology 1995; 102(12): 1760–9.

Khalili MA, Diestelhorst M, Krieglstein GK. Long-term follow-up of 700 trabeculectomies. Klin Monbl Augenheilkd 2000; 217(1): 1–8; discussion 9. (German)

Ehrnrooth P, Lehto I, Puska P, Laatikainen L. Long-term out-come of trabeculectomy in terms of intraocular pressure. Acta Ophthalmol Scand 2002; 80(3): 267–71.

European Glaucoma Society. Terminology and guidelines for glaucoma. 3rd ed. Italy, Savona: Editrice DOGMA; 2008. p. 155–6.

Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90(3): 262–7.

Razeghinejad MR, Fudemberg SJ, Spaeth GL. The changing con-ceptual basis of trabeculectomy: A review of past and current surgical techniques. Surv Ophthalmol 2012; 57(1): 1–25.

Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R. CIGTS Study Group. Intraocular pressure control and long-term visual field loss in Collaborative Initial Glaucoma Treat-ment Study. Ophthalmology 2011; 118(9): 1766–73.

Cvetkovic D, Blagojevic M, Dodic V. Experience with trepanotra-beculectomy. ActaOphthalmol (Copenh) 1978; 56(1):150–60.

Palmberg P. How clinical trial results are changing our thinking about target pressures. Curr Opin Ophthalmol 2002; 13(2): 85–8.

Molteno AC, Bevin TH, Herbison P, Husni MA. Long-term re-sults of primary trabeculectomies and Molteno implants for primary open-angle glaucoma. Arch Ophthalmol 2011; 129(11): 1444–50.

Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. II. Variations in operative technique and outcome. Eye (Lond) 2001; 15(Pt 4): 441–8.

Law SK, Shih K, Tran DH, Coleman AL, Caprioli J. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. Am J Ophthalmol 2009; 148(5): 685–95. e1.

Casson R, Rahman R, Salmon JF. Long term results and compli-cations of trabeculectomy augmented with low dose mitomy-cin C in patients at risk for filtration failure. Br J Ophthalmol 2001; 85(6): 686–8.

Diestelhorst M, Khalili MA, Krieglstein GK.Trabeculectomy: A retrospective follow-up of 700 eyes. Int Ophthalmol 1998–1999; 22(4): 211–20.

Molteno AC, Bosma NJ, Kittelson JM. Otago glaucoma surgery outcome study: Long-term results of trabeculectomy: 1976 to 1995. Ophthalmology 1999; 106(9): 1742–50.

Tornqvist G, Drolsum LK. Trabeculectomies: A long-term study. Acta Ophthalmol (Copenh) 1991; 69(4): 450–4.

Popovic V, Sjöstrand J. Long term outcome following trabecu-lectomy: I Retrospective analysis of intraocular pressure regu-lation and cataract formation. Acta Ophthalmol (Copenh) 1991; 69(3): 299–304.

Watson PG, Jakeman C, Ozturk M, Barnett MF, Barnett F, Khaw KT. The complications of trabeculectomy: A 20-year follow-up. Eye 1990; 4(Pt 3): 425–38.

Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond) 2002; 16(3): 297–303.

Serguhn S, Spiegel D. Comparison of postoperative recovery af-ter trabeculectomy for pseudoexfoliation glaucoma and chron-ic primary open angle glaucoma. Klin Monbl Augenheilkd 1999; 215(5): 281–6. (German)

Mietz H, Raschka B, Krieglstein GK. Risk factors for failures of trabeculectomies performed without antimetabolites. Br J Ophthalmol 1999; 83(7): 814–21.